Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort.
Hung TM, Jayanti RP, Lee HY, Kim HJ, Mok J, Jang TW, Oh JY, Kim JS, Ko Y, Min J, Hoa PQ, Ahn S, Long NP, Cho YS, Shin JG; cPMTb. Hung TM, et al. Among authors: jayanti rp. Int J Antimicrob Agents. 2023 Aug;62(2):106840. doi: 10.1016/j.ijantimicag.2023.106840. Epub 2023 May 7. Int J Antimicrob Agents. 2023. PMID: 37160240 Free article.
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure.
Hoa PQ, Kim HK, Jang TW, Seo H, Oh JY, Kim HC, Shin AY, Min J, Jayanti RP, Hung TM, Anh NK, Ahn S, Long NP, Cho YS, Shin JG; cPMTb. Hoa PQ, et al. Among authors: jayanti rp. Int J Antimicrob Agents. 2024 Feb;63(2):107034. doi: 10.1016/j.ijantimicag.2023.107034. Epub 2023 Nov 16. Int J Antimicrob Agents. 2024. PMID: 37977236 Free article.
Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis.
Soedarsono S, Jayanti RP, Mertaniasih NM, Kusmiati T, Permatasari A, Indrawanto DW, Charisma AN, Yuliwulandari R, Long NP, Choi YK, Hoa PQ, Hoa PV, Cho YS, Shin JG. Soedarsono S, et al. Among authors: jayanti rp. Int J Infect Dis. 2022 Apr;117:8-14. doi: 10.1016/j.ijid.2022.01.003. Epub 2022 Jan 10. Int J Infect Dis. 2022. PMID: 35017103 Free article.
Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis.
Soedarsono S, Jayanti RP, Mertaniasih NM, Kusmiati T, Permatasari A, Indrawanto DW, Charisma AN, Lius EE, Yuliwulandari R, Quang Hoa P, Ky Phat N, Thu VTA, Ky Anh N, Ahn S, Phuoc Long N, Cho YS, Shin JG. Soedarsono S, et al. Among authors: jayanti rp. Tuberculosis (Edinb). 2023 Mar;139:102325. doi: 10.1016/j.tube.2023.102325. Epub 2023 Feb 14. Tuberculosis (Edinb). 2023. PMID: 36841141 Free article.
Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance.
Kim R, Jayanti RP, Lee H, Kim HK, Kang J, Park IN, Kim J, Oh JY, Kim HW, Lee H, Ghim JL, Ahn S, Long NP, Cho YS, Shin JG, On Behalf Of The cPMTb. Kim R, et al. Among authors: jayanti rp. Front Pharmacol. 2023 May 26;14:1116226. doi: 10.3389/fphar.2023.1116226. eCollection 2023. Front Pharmacol. 2023. PMID: 37305528 Free PMC article.